Celgene (CELG) volatility elevated into acquiring Juno Therapeutics for approximately $87 per share in cash

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. PLTR
7. MSFT
8. NAVN
9. DFTX
10. CNC

Go back to Celgene (CELG) volatility elevated into acquiring Juno Therapeutics for approximately $87 per share in cash

Notable Call Buying Activity Continues in Celgene (CELG) Following Reported Acquisition of Juno Therapeutics (JUNO) -Susquehanna

January 23, 2018 1:41 PM EST

Susquehanna options strategist Alison Edwards notes call buying activity in Celgene (NASDAQ: CELG), as an investor bought 3k Mar 110 Calls for $2.85, adding to Feb call buying yesterday, following CELG's reported acquisition of Juno Therapeutics (NASDAQ: JUNO) for $87 per share.

... More